PA
TDUP icon

PharVision Advisers’s ThredUp TDUP Stock Holding History

PharVision Advisers’s Portfolio TDUP Stock Details TDUP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-41,066
Closed -$262K – 590
2025
Q4 		$262K Buy
41,066
+15,590
+61% +$126K 0.13% 359
2025
Q3 		$241K Buy
+25,476
New +$241K 0.14% 358

Other funds holding TDUP

NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

PharVision Advisers's TDUP Position: Q1 2026 in Review

PharVision Advisers sold out of ThredUp (TDUP) in Q1 2026, closing a stake of 41,066 shares — an estimated $262K sold.

PharVision Advisers first reported a position in TDUP in Q3 2025 and held it in 2 quarters. The position peaked at $262K in Q4 2025. 174 funds tracked by Wall St. Rank hold TDUP as of Q1 2026.

  • PharVision Advisers reported no remaining ThredUp position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 41,066 ThredUp shares in Q1 2026, an estimated $262K.
  • PharVision Advisers first reported a position in ThredUp in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's ThredUp position peaked at $262K in Q4 2025.
  • 174 funds tracked by Wall St. Rank held ThredUp as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.